GMRE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GMRE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.
As of today, Global Medical REIT's Total Revenue Growth Rate (Future 3Y To 5Y Est) is N/A.
For the REIT - Healthcare Facilities subindustry, Global Medical REIT's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the REITs industry and Real Estate sector, Global Medical REIT's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:
* The bar in red indicates where Global Medical REIT's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.
Global Medical REIT (NYSE:GMRE) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation
Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.
In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.
Thank you for viewing the detailed overview of Global Medical REIT's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.
Moore Roscoe M Jr | director | C/O HEMOBIOTECH, INC., 5001 SPRING VALLEY ROAD, SUITE 1040 WEST, DALLAS TX 75244 |
Henry Cole | director | 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814 |
Jeffrey Busch | director, officer: Chairman, President and CEO | 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814 |
Lori Wittman | director | 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606 |
Matthew Cypher | director | 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814 |
Paula Crowley | director | 2 BETHESDA METRO CENTER, SUITE 440, BETHESDA MD 20814 |
Ronald Marston | director | 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814 |
Robert J Kiernan | officer: Chief Financial Officer | 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814 |
Alfonzo Leon | officer: Chief Investment Officer | 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814 |
Danica Holley | officer: Chief Operating Officer | 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814 |
Jamie Allen Barber | officer: Secretary and General Counsel | 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814 |
Allen Webb | officer: SVP | 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814 |
Huiqi Zhang | director, 10 percent owner | 40-44 WYNDHAM STREET, 24/F WYNDHAM PLACE, HONG KONG K3 00000 |
Notable Reward Ltd | 10 percent owner | VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110 |
Superior Glory Enterprises Ltd. | 10 percent owner | VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110 |
From GuruFocus
By Business Wire Business Wire • 12-07-2022
By Business Wire Business Wire • 06-09-2023
By Business Wire Business Wire • 07-12-2022
By GF Value GF Value • 06-09-2021
By GuruFocus Research • 12-25-2023
By Business Wire Business Wire • 05-04-2021
By Business Wire • 09-08-2023
By Business Wire Business Wire • 01-30-2023
By Business Wire Business Wire • 04-22-2021
By Business Wire Business Wire • 01-31-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.